期刊文献+

宫颈癌合并深静脉血栓30例临床分析 被引量:4

Clinical analysis of the relation of uterine cervix cancer and thromboembolic disease in 30 cases
下载PDF
导出
摘要 目的:静脉血栓栓塞症(VTE)是恶性肿瘤患者常见并发症。本文结合文献分析我院住院病人宫颈癌患者静脉血栓的临床特征,分析VTE形成机制及诱发因素,探索最佳治疗方法。方法:对近5年我科收治的宫颈癌合并深静脉血栓30例患者的临床资料进行分析。结果:30例患者中17例VTE的发生和介入手术化疗有关。2例(6.7%)血栓栓塞发生在宫颈癌确诊之前,28例(93.3%)发生在宫颈癌确诊之后,单纯并发下肢深静脉血栓形成(DVT)27例,合并肺栓塞(PTE)2例,DVT合并PTE 1例。22例在栓塞前有化疗史。结论:血栓可能为肿瘤病人的首发表现,病人出现不能解释的血栓栓塞性疾病应考虑有肿瘤的可能。抗凝治疗对于血栓栓塞症疗效确切。及时诊断和治疗可以延长患者的生存期,降低患者的死亡率。口服避孕药、口服甲地孕酮、介入手术与VTE的发生几率可能有关。分期晚,远地转移的肿瘤患者易出现血栓栓塞。 Objective:Venous thromboembolism(VTE)is the common complication in malignant tumor patients.Methods:Clinical data of 30 patients of uterine cervix cancer with TD confirmed by pathology and cytology in recent 5 years were analyzed.Results:Of 30 cases 17(56.67%)of VTE had relation with intervention operation.2 cases(6.7%)of VTE occurred before diagnosis of uterine cervix cancer.28 cases(93.3%) after diagnosis of uterine cervix cancer.There were 27 cases with only deep venous thrombosis(DVT),2 cases with only pulmonary thromboembolism(PTE),1 case with DVT and PTE,22 cases had chemotherapy history.Conclusion:VTE sometimes is the first representation in cancer patients.If VTE occurred and can not be complained for some common motivations,we should consider neoplasm.anticoagulant therapy is the best therapeutics for VTE,early diagnosis and right treatment can lengthen the life span.oral contraceptives or megestrol and accepting intervention operation may have correlation with VTE.advanced stage,metastatic tumor may easily occur VTE.
出处 《现代肿瘤医学》 CAS 2011年第4期761-763,共3页 Journal of Modern Oncology
关键词 宫颈癌 血栓栓塞症 肺栓塞 uterine cervix cancer thromboembolic disease pulmonary thromboembolism
  • 相关文献

参考文献10

  • 1Levitan N,Dowlati A,Remick SC,et al.Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy.Risk analysis using Medicare claims data[J].Medicine(Baltimore),1999,78:285-291.
  • 2Hyers TM,Agnelli G,Hull RD,et al.Antithromblic therapy for venous thromboembolic disease[J].Chest,2001,199(1 Suppl):176-193.
  • 3Prandoni P,Lensing AW,Buller HR,et al.Deep-vein thrombosis and the incidence of subsequent symptomatic cancer[J].N Engl Med,1992,327:1128-1133.
  • 4Khorana AA,Francis CW,Culakova E,et al.Frequency,risk factors,and trends for venous thromboembolism among hospitalized cancer patients[J].Cancer,2007,110(10):2339-2346.
  • 5Thodiyil PA,Kakkar AK.Variation in relative risk of venous thromboembolism in different cancers[J].Thromb Haemost,2002,87:1076-1077.
  • 6Alok A,Khorana James P,et al.The NCCN clinical practice guidelines on venous thromboembolic disease:strategies for Improving VTE prophylaxis in hospitalized cancer patients[J].Oncologist,2007,12:1361-1370.
  • 7Monreal M,Lafoz E,Casals A,et al.Occult cancer in patients with venous thrombosis:a systematic approach[J].Cancer,1991,67:541-545.
  • 8Akl EA,Kamath G,Kim SY,et al.Oral anticoagulation for prolonging survival in patients with cancer[J].Cochrane Database Syst Rev,2007,18(2):CD006466.
  • 9Altinbas M,Coskun HS,Er O,et al.A randomized clinical trial of combination chemotherapy with and without low molecular-weight heparin in small cell lung cancer[J].J Thromb Haemost,2004,2:1266-1271.
  • 10Saulius Pa(s)kauskas,Juozas Pundzius,Giedrius Barauskas Venous thromboembolism and prophylaxis in cancer patients[J].Medicina (Kaunas),2008,44(3):175-181.

同被引文献51

  • 1滑艳.宫颈癌患者的凝血象研究[J].中国医药导报,2006,3(23):58-59. 被引量:6
  • 2白丽萍,门剑龙.恶性转移瘤患者高凝状态的研究[J].中国慢性病预防与控制,2006,14(4):241-242. 被引量:19
  • 3毛伟征,苏东明,李雪萍.癌症分期手册.6版.沈阳:辽宁科学技术出版社,2005:33-45.
  • 4Drixler TA, Borel Rinkes IH, Ritchie ED, ct al. Continuous ad- ministration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res, 2000,60 (6) : 1761-1765.
  • 5Rickles FR, Levine MN. Epidemicology of thrombosis in cancer [ J ]. Acta Haematol, 2002,106: 6-12.
  • 6Bruyere F, Melen-Lamalle L, Blacher S, et al. Does plas- minogen activator inhibitor- 1 drive lymphangiogenesis [ J ]. PLoS One, 2010,5(1) :9653.
  • 7Hoffmann AC, Mori R, Vallbohmer D, et al. High expres- sion of HIFla is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF and b - FGF [ J ]. Neoplasia ( New York, NY) ,2008,10(7) :674-679.
  • 8Chang YT, Chang MC, Wei SC, et al. Serum vascular en- dothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer[ J ]. Pancreas, 2005,37 (2) : 145-150.
  • 9Jenab Y, Ghaffari-Marandi N, Safir A, et al. Sex-related changes in tissue Doppler imaging parameters among patients with acute pulmonary thromboembolism[J]. J Ultrasound Med, 2013, 32(11):1997-2005.
  • 10Grant JD, Stevens SM, Woller SC, et al. Diagnosis and management of upper extremity deep-vein thrombosis inadults[J]. Thromb Haemost, 2012, 108(6): 1097-1108.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部